TAKEDA PHARMACEUTIC-SP ADR (TAK) Institutional Ownership and Insiders Activity
TAKEDA PHARMACEUTIC-SP ADR (TAK) is widely held by institutional investors, with 383 firms reporting positions valued at approximately $1.68B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Capital Research Global Investors is the largest disclosed holder, reporting approximately $309.34M in TAK holdings in its latest filing.
Recent insider activity includes 19 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
383
Total Reported Value
$1.68B
Largest Holder
Capital Research Global Investors
Largest Position
$309.34M
Insider Transactions (90d)
19
Latest Filing Quarter
Q2 2026
New Institutional Positions
58
Funds Exiting Positions
40
Top Institutional Owners
View allInvestorReported Balance
- Capital Research Global Investors$309.34M
- Fmr Llc$153.88M
- Morgan Stanley$112.13M
- Adage Capital Partners Gp, L.L.C.$96.99M
- Goldman Sachs Group Inc$82.15M
Related TAK Institutional Insights:
- TAK 13F Institutional Holders
- TAK Superinvestors
- TAK Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- TAK Insider Trading & SEC Form 4 Activity
- TAK Articles
- Top Institutional Investor Stock Rankings